Navigation Links
Enterovirus Panel II

ProductsEnterovirus Panel II
Company ARUP Laboratories
Item Enterovirus Panel II
Features 
Description ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info ARUP Laboratories
Customer Service: (800) 522-2787
Web site: http://www.aruplab.com

Related medicine products :

1. Enterovirus ASR
2. Enterovirus Culture
3. Enterovirus Detection by RT-PCR
4. Enterovirus Typing
5. Farnsworth Panel D15 test evaluation
6. B-VAT® Flat Panel Color Compatible Monitor
7. Sony Flat Panel Displays with C3269 Articulating Arm
8. QuickScreen™ Multi-Panel Dip Card
9. QuickScreen Multi-Panel Dip Card
10. InstaCup 5 Drug Screen Panel
11. Autoimmunity Screening Panel 1
The LightCycler System is the smartest innovation for more efficient PCR. The LightCycler System enables you to perform rapid PCR in less than 30 min, and simultaneously quantify and analyze the resu
Chemically Resistant Sealing Mat for 384ch, Square Well Available Sterile
Silicone Compression Mat, Bulk
...e Moto Alpha unit, these new pads may be used in a...eral successive runs may be sealed with the same p... a microplate from sticking to the block and lid, ... sealing performance, which means you can use as l...
Medicine Products:
(Date:12/3/2008)...wire-FirstCall/ -- ThermoGenesis,Corp. (Nasdaq: ... and services,that process and store adult stem c...all on Thursday, December 4, to discuss its announ...ompany. , The conference call will begin at...tern Standard Time). The call can be accessed by c...
(Date:12/3/2008)...elped by maintenance treatment, study shows , ...tenance therapy using low-dose peginterferon doesn... who haven,t responded to an initial round of trea...showed a surprising health decline in patients wit..., "This course of treatment had been adopted by a ...
(Date:12/3/2008)...lood thinner imported from China , , WED...on the deadly contamination of the blood thinner h...an-made chemical that was added to batches of the ...t. , The crisis, which began last November, res...eaths in the United States. The Chinese heparin, c...
(Date:12/3/2008)... Baccalaureate Student Population May Signal that ..., WASHINGTON, Dec. 3 ...ACN) today released preliminary survey data showin...sing programs increased by only 2.0 percent from 2...tive year of enrollment growth, the annual increas...
Breaking Medicine News(10 mins):Health News:ThermoGenesis Corp. Schedules Conference Call/Webcast to Discuss Management Transition 2Health News:Hepatitis C Therapy Useless for Some 2Health News:Report Confirms Source of Contaminated Heparin 2Health News:Report Confirms Source of Contaminated Heparin 3Health News:Enrollment Growth in U.S. Nursing Colleges and Universities Hits an 8-Year Low According to New Data Released by AACN 2Health News:Enrollment Growth in U.S. Nursing Colleges and Universities Hits an 8-Year Low According to New Data Released by AACN 3Health News:Enrollment Growth in U.S. Nursing Colleges and Universities Hits an 8-Year Low According to New Data Released by AACN 4Health News:Enrollment Growth in U.S. Nursing Colleges and Universities Hits an 8-Year Low According to New Data Released by AACN 5
...tion has found that more than 60 percent of people... off food debris// struck in between their teeth. ...es and knives are in common use, the survey said. ...at 23 percent leave food stuck in between their te...
...ientific value of Ayurveda before the European Med... presentation on the potential role of Ayurveda in... here Friday. The presentation is being done unde...uropean Union Joint Working Group on Pharmaceutica...
...rtality rate in Madhya Pradesh, Bhopal Archbishop ...elp check the menace//. With 13,000 reported death...l mortality rate of the state is one of the highes...ng a women's meet at the missionary-run Asha Niket...
...earch Institute at the University of Massachusetts... responsible for air pollution//. This list is off...ies are listed as an important source of air pollu...f chemicals from industrial facilities across the ...
Other Medicine News:
(Date:12/1/2008)...TargeGen has announced that an oral,presentation ...sed clinical,trial of TG101348 in myeloproliferat...08 American Society of Hematology (ASH) Meeting. ,...ws:, Title: A Phase I Study of ... JAK2-Selective Inhibitor, in Patients with...
(Date:12/1/2008)...-- Roche announced today that a,comparative study...in and,discomfort associated with blood glucose t...systems and lancing devices were deemed least pain... ACCU-CHEK Aviva and ACCU-CHEK Compact,Plus blood...iclix, ACCU-CHEK,Softclix and ACCU-CHEK Softclix ...
(Date:12/1/2008)...e is a two-way switch that, if turned off, causes ...that they lose their identity and become more like..., Dec. 1 Scientists at...ered that a certain differentiated cell type is so... constant expression of a gene called Prox1 to d...
(Date:12/1/2008)...ewswire-FirstCall/ -- Genaera Corporation (Nasdaq... has begun in study MSI-1436C-102 (Study 102), the...uemine (MSI-1436) in overweight and obese type 2 d...treatment of type 2 diabetes and obesity which wor...and leptin pathways through the highly selective i...
Breaking Medicine Technology:Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful 2Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful 3Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3Physical activity after bariatric surgery improves weight loss quality of life 29950 1Physical activity after bariatric surgery improves weight loss quality of life 29950 2Gaps in adhesion 5896 1Smoking May Harm the Egg Embryo 29947 1Smoking May Harm the Egg Embryo 29947 2Money motivates doctors to reduce ethnic differences in heart disease treatments 29943 1Money motivates doctors to reduce ethnic differences in heart disease treatments 29943 2
...w Study Results Show Antibodies Against Cancer-Cau... Times Greater Than Natural,Infection Levels, CHIC...ata show,that at 18 months after the first of a th...5 vaccinated with the GlaxoSmithKline,(GSK) cervic...,against the two most common cancer-causing human ...
...HICAGO, DARMSTADT, Germany, June 5, 2007 – T...logy (ASCO) meeting,in Chicago sees a wealth of pr...quo;s targeted cancer therapy Erbitux®,(cetuxi...y and,versatility of this agent in both first-line... cancer (mCRC) and squamous cell,carcinoma of the ...
Other Medicine Technology:Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides,Sustained Immune Response in 100 Percent of Women up to 55 Years of,Age 2Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides,Sustained Immune Response in 100 Percent of Women up to 55 Years of,Age 3Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides,Sustained Immune Response in 100 Percent of Women up to 55 Years of,Age 4Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides,Sustained Immune Response in 100 Percent of Women up to 55 Years of,Age 5Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of,Erbitux for Colorectal and Head and Neck Cancer Patients 2Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of,Erbitux for Colorectal and Head and Neck Cancer Patients 3Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of,Erbitux for Colorectal and Head and Neck Cancer Patients 4Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of,Erbitux for Colorectal and Head and Neck Cancer Patients 5Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of,Erbitux for Colorectal and Head and Neck Cancer Patients 6Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of,Erbitux for Colorectal and Head and Neck Cancer Patients 7Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of,Erbitux for Colorectal and Head and Neck Cancer Patients 8